Dual-eligible Medicare–Medicaid status is associated with lower surgeon reimbursement despite greater medical and psychosocial complexity in total shoulder arthroplasty Authors: Steven G Persaud, Colin C Neitzke, Simon Ortiz, Michael C Fu, Samuel A Taylor, Joshua S Dines, Gabriella E Ode, David M Dines, Lawrence V Gulotta, Christopher M Brusalis Published: 2026 ABSTRACT AbstractBackgroundDual eligibility for Medicare and Medicaid is a well-established marker of socioeconomic vulnerability, but its association with health disparities in total shoulder arthroplasty (TSA) has not been evaluated. This study aimed to evaluate whether the proportion of dual-eligible beneficiaries in TSA surgeons' Medicare panels was associated with standardized Medicare reimbursement.MethodsA retrospective, cross-sectional analysis of the publicly available “Centers for Medicare and Medicaid Services Physician and Other Practitioners” file for 2023 was performed. Surgeons performing primary TSA were identified using Current Procedural Terminology code 23472. Surgeon-level dual-eligibility proportion was defined as the percentage of dual-eligible beneficiaries within each surgeon's Medicare patient panel and categorized into quartiles. Outcomes included TSA volume and mean standardized Medicare reimbursement per TSA. Surgeon panel characteristics, including Hierarchical Condition Category score, minority composition, and behavioral health conditions (anxiety and depression), were also assessed.ResultsA total of 3,439 surgeons performing 93,167 primary TSA procedures were identified, of which, 2,623 surgeons had data available for all variables used in quartile-based analyses. The mean TSA volume per surgeon was 27.09 ± 19.42 cases. Higher dual-eligibility proportion was independently associated with lower standardized reimbursement per TSA (lowest quartile [Q1]: $936.20 vs. highest quartile [Q4]: $799.18; P < .001). Higher dual-eligibility proportion was also associated with greater beneficiary risk (Hierarchical Condition Category score: 1.02 vs. 1.21; P < .001) and increased minority composition (P < .001). The distribution of surgeons by rurality did not differ significantly across quartiles (P = .052).ConclusionSurgeons with higher proportions of dual-eligible beneficiaries in their Medicare panels receive lower standardized reimbursement while managing more medically and psychosocially complex patient panels. These findings suggest that the current reimbursement structure may create financial disincentives for surgeons treating this socioeconomically vulnerable population, with implications for equitable access to TSA care.Keywords: Dual eligibility, Medicare, Medicaid, Total shoulder arthroplasty, Healthcare disparities, Surgeon reimbursement, Socioeconomic vulnerability Total shoulder arthroplasty (TSA) has experienced exponential growth, driven by an aging population as well as expanded indications and surgeon experience, with incidence increasing from 13.1 to 45.6 per 100,000 between 2015 and 2025.13,22 Despite this growth, access to TSA has not been distributed equitably. Several factors including socioeconomic disadvantage, insurance status, and minority race/ethnicity have been associated with lower TSA utilization, higher perioperative complication rates, and decreased patient-reported outcomes.2,8,24 One of the most robust markers of socioeconomic vulnerability is dual eligibility status for Medicare and Medicaid.1 These beneficiaries, enrolled in both federal programs, represent a subset of the Medicare population with a disproportionate degree of chronic medical comorbidities, behavioral health conditions, and functional limitations, often experiencing worse health outcomes than Medicare-only enrollees.21 Dual eligibility status acts as a proxy for patients whose socioeconomic complexity, care coordination needs, and clinical risk extend beyond what standard comorbidity indices capture.11,15,16 Prior research has largely characterized socioeconomic disparities via perioperative patient outcomes, with far less attention paid to the characteristics of surgeons that these patients are able to access for care. The objective of the present study was to use dual-eligibility status as a marker for social vulnerability and examine whether dual-eligibility status within TSA surgeons' Medicare panel was independently associated with their standardized Medicare reimbursement. We hypothesized that surgeons caring for higher proportions of dual-eligible patients would receive lower standardized Medicare reimbursement, despite managing patients with greater medical and psychosocial complexity. Methods Data source A retrospective, cross-sectional analysis of the publicly available Centers for Medicare and Medicaid Services (CMS) “Physician and Other Practitioners” dataset for the year 2023 was performed. This dataset reports annual procedure-level billing records for Medicare fee-for-service patients, including National Provider Identifier, procedure counts, beneficiary panel characteristics, and reimbursement data. Primary TSA procedures were identified using the Current Procedural Terminology (CPT) code 23472. Surgeons were included if they submitted at least 11 Medicare claims for primary TSA, as this is the minimum threshold for inclusion in the CMS database. As this dataset contains no individually identifiable patient information, institutional review board approval was not required. Study variables The primary exposure was surgeon-level dual-eligibility proportion, defined as the proportion of a surgeon's Medicare beneficiary panel that was dually enrolled in Medicare and Medicaid during the study year, expressed as a percentage. Dual-eligibility proportion was categorized into quartiles among surgeons with data available for all study variables; Q1 represented the lowest quartile and Q4 the highest. The primary outcome was the mean standardized Medicare reimbursement per TSA. Standardized payments, as defined by CMS, adjust for geographic variation in reimbursement (including the Geographic Practice Cost Index and local wage indices), allowing for cross-regional comparisons independent of practice location. Surgeon panel covariates included the average Hierarchical Condition Category (HCC) risk score, the proportion of racial and ethnic minority beneficiaries, and practice rurality. The CMS-HCC risk score uses groups of diagnostic codes to adjust payments based on differences in expected healthcare spending utilizing both demographic factors and diagnosis-based comorbidities.7 The risk score is calibrated so that a score of 1.0 reflects the average Medicare beneficiary, and those >1.0 indicate proportionally higher predicted healthcare expenditures. Practice rurality was classified using Rural-Urban Commuting Area codes provided in the CMS dataset and dichotomized as rural vs. non-rural. Dual eligibility, HCC score, minority composition, anxiety, and depression were surgeon-level panel measures reflecting each surgeon's overall Medicare beneficiary panel. Anxiety and depression were CMS-reported beneficiary percentages. TSA volume and standardized reimbursement were derived from CPT 23472 claims and were procedure-specific. Statistical analysis Descriptive statistics were computed for the full cohort of 3,439 surgeons performing TSA. Quartile-based comparisons of continuous variables were performed using one-way analysis of variance, while categorical variables were compared using the chi-square test. These analyses were restricted to the 2,623 surgeons with data available for all analytic variables. Multivariable linear regression was used to evaluate the independent association between continuous dual-eligibility proportion and mean standardized Medicare reimbursement and annual TSA volume, with adjustment for rurality, average beneficiary HCC risk score, and minority patient proportion. Quartile-based analyses required nonmissing data for dual-eligibility proportion, TSA volume, standardized reimbursement, HCC score, minority proportion, rurality, anxiety, and depression. Covariates were selected a priori to account for patient complexity and practice geography. Statistical significance was defined as P < .05. All analyses were performed in R version 4.3 (R Foundation for Statistical Computing, Vienna, Austria). Results Surgeon and practice characteristics A total of 3,439 surgeons performing 93,167 primary TSA procedures were identified in the 2023 CMS dataset (Table I). The mean annual TSA volume per provider was 27.09 ± 19.42 cases, with a median of 20 (interquartile range, 12 to 33), consistent with a right-skewed distribution and concentration of procedural volume among a subset of high-volume providers. Table IPrimary total shoulder arthroplasty surgeon characteristics in 2023VariableOverall (N = 3,439)∗Total primary TSA services93,167TSA services per surgeon, mean (SD)27.09 (19.42)TSA services per surgeon, median (IQR)20 (12–33)Dual-eligible beneficiaries (%), mean (SD)9.99 (6.85)Minority beneficiaries (%), mean (SD)5.05 (4.12)Beneficiary age (yr), mean (SD)73.66 (2.84)Hierarchical Condition Category (HCC), mean (SD)1.08 (0.21)Standardized reimbursement per TSA ($), mean (SD)762.17 (433.70)Rural practice location, n (%)234 (6.8%)TSA, total shoulder arthroplasty.∗Values are presented as mean (standard deviation [SD]) or median (interquartile range [IQR]) unless otherwise specified. Primary total shoulder arthroplasty surgeon characteristics in 2023 TSA, total shoulder arthroplasty. Values are presented as mean (standard deviation [SD]) or median (interquartile range [IQR]) unless otherwise specified. Across patient panels, the mean proportion of dual-eligible beneficiaries was 9.99% ± 6.85%, and the mean minority beneficiary proportion was 5.05% ± 4.12%. The mean beneficiary age was 73.66 ± 2.84 years, and the mean HCC risk score was 1.08 ± 0.21. The mean standardized Medicare reimbursement per TSA was $762.17 ± $433.70. Most TSA surgeons practiced in metropolitan settings (86.3%), with 9.3% in micropolitan and 4.4% in rural or small-town locations (Table II). Quartile-based analyses included 2,623 surgeons (76.3% of the full cohort); 816 surgeons were excluded because one or more required analytic fields were missing. Available panel characteristics were similar between surgeons included in the quartile-based analyses and the full cohort in mean TSA volume (27.14 vs. 27.09 cases), dual-eligibility proportion (10.03% vs. 9.99%), HCC score (1.10 vs. 1.08), and minority proportion (5.98% vs. 5.05%). Mean standardized reimbursement was $849.00 among surgeons included in quartile-based analyses and $762.17 in the full cohort. Table IIDistribution of TSA-performing surgeons by practice rurality in 2023Rurality∗Number of surgeonsPercent (%)Metropolitan2,96886.3Micropolitan3199.28Rural/small town1524.42TSA, total shoulder arthroplasty.∗Rurality categories were defined using Rural-Urban Commuting Area (RUCA) classifications as provided in the Centers for Medicare and Medicaid Services (CMS) dataset. Distribution of TSA-performing surgeons by practice rurality in 2023 TSA, total shoulder arthroplasty. Rurality categories were defined using Rural-Urban Commuting Area (RUCA) classifications as provided in the Centers for Medicare and Medicaid Services (CMS) dataset. Impact of dual-eligibility on standardized reimbursement Of the 3,439 surgeons identified, 2,623 were included in quartile-based analyses after excluding surgeons with missing analytic data. As shown in Table III, higher dual-eligibility proportion was associated with significantly lower mean standardized reimbursement per TSA (P < .001), declining from $936.20 in Q1 to $834.90 in Q2, $825.66 in Q3, and $799.18 in Q4 (Fig. 1). This reimbursement gradient persisted despite standardization for geographic payment variation. Higher dual-eligibility proportion also co-occurred with progressively lower TSA volume across quartiles, declining from 34.52 cases in Q1 to 20.78 in Q4 (P < .001) (Fig. 2). Because dual-eligibility proportion is a surgeon-level panel measure and is not TSA-specific, these data demonstrate association only and cannot determine whether an individual dual-eligible TSA patient generated lower reimbursement. Table IIIPatient panel and practice characteristics by dual-eligibility proportion quartiles among total shoulder arthroplasty surgeons in 2023VariableQ1Q2Q3Q4P valueNumber of surgeons656656656655—TSA services per surgeon, mean34.5228.4124.8120.78<.001Standardized reimbursement per TSA, mean ($)936.20834.90825.66799.18<.001Hierarchical Condition Category (HCC), mean1.021.061.111.21<.001Minority beneficiaries (%), mean5.985.505.407.03<.001Anxiety (%), mean24.2425.1526.2828.76<.001Depression (%), mean22.2523.7124.9027.45<.001Rural practice location n, (%)1 (0.15)4 (0.61)2 (0.30)8 (1.22).052TSA, total shoulder arthroplasty; Q1, lowest dual-eligibility proportion quartile; Q4, highest dual-eligibility proportion quartile.Quartile analyses include 2,623 surgeons with complete data. Patient panel and practice characteristics by dual-eligibility proportion quartiles among total shoulder arthroplasty surgeons in 2023 TSA, total shoulder arthroplasty; Q1, lowest dual-eligibility proportion quartile; Q4, highest dual-eligibility proportion quartile. Quartile analyses include 2,623 surgeons with complete data. Mean standardized Medicare reimbursement per primary TSA across surgeon dual-eligibility proportion quartiles. Error bars represent 95% confidence intervals. TSA, total shoulder arthroplasty. Mean annual primary TSA volume per surgeon across dual-eligibility proportion quartiles. Error bars represent 95% confidence intervals. TSA, total shoulder arthroplasty. Multivariable analyses In multivariable linear regression modeling, higher dual-eligibility proportion remained independently associated with lower mean standardized Medicare reimbursement per TSA after adjustment for rurality, beneficiary HCC risk score, and minority beneficiary proportion (β = −7.751, P < .001). Rural practice was also associated with lower reimbursement (β = −412.028, P < .001), while minority beneficiary proportion was associated with higher reimbursement (β = 14.023, P < .001); HCC risk score was not significant (β = 76.177, P = .146). In a separate model, higher dual-eligibility proportion was independently associated with lower annual TSA volume (β = −0.736, P < .001). Patient complexity and practice rurality Surgeons in higher dual-eligibility proportion quartiles had patient panels with substantially greater medical and social complexity. The mean HCC risk score increased from 1.02 in Q1 to 1.21 in Q4 (P < .001), indicating higher predicted healthcare expenditure. Minority panel composition was also significantly higher in Q4 (7.03%) compared to Q1 (5.98%) (P < .001). Anxiety and depression were also more prevalent in Q4 than Q1 (28.76% vs. 24.24% and 27.45% vs. 22.25%, respectively; both P < .001). Practice rurality did not differ significantly across dual-eligibility quartiles (P = .052; Fig. 3). Patient complexity metrics across surgeon dual-eligibility proportion quartiles, including HCC risk score, anxiety, depression, and minority beneficiary proportion. Error bars represent 95% confidence intervals. HCC, Hierarchical Condition Category. Discussion As shoulder arthroplasty volume continues to increase, ensuring equitable access to high-quality shoulder arthroplasty care remains critical. We performed a retrospective, cross-sectional analysis of the publicly available 2023 CMS Physician and Other Practitioners file to evaluate whether surgeon-level dual-eligibility proportion was associated with surgeon TSA volume and standardized Medicare reimbursement. We found that surgeons with higher dual-eligibility proportions received lower standardized reimbursement and had more medically and psychosocially complex Medicare patient panels. Together, these findings highlight a troubling intersection of potential patient access inequity and surgeon financial disincentive, in which reduced reimbursement may be limiting the most complex patients' access to higher-volume TSA surgeons. It is well established that increasing surgeon TSA volume is associated with improved perioperative outcomes including decreased complication rates, shorter operative time, reduced length of stay, and lower costs.3,4,9,20,23 Best et al3 performed a retrospective review of CMS data from 2015 to 2021 and found that surgeons performing ≥10 and ≥29 anatomic TSA annually had 27% and 33% decreased odds of revision within 2 years, respectively, compared to surgeons performing fewer than 4 per year. Similar trends were observed for reverse TSA. In the present study, dual-eligibility proportion, stratified into quartiles (Q1 lowest, Q4 highest), demonstrated a stepwise inverse relationship with surgeon annual TSA volume, with mean case volume declining from 34.52 in Q1 to 20.78 in Q4, a 40% reduction. This relationship remained significant after multivariable linear regression modeling (β = −0.736, P < .001), suggesting that surgeons with higher dual-eligibility proportions operate in lower-volume practice settings, which has previously been associated with higher perioperative risk. Surgeons in higher dual-eligibility proportion quartiles had patient panels with significantly greater medical complexity. The mean HCC risk score increased from 1.02 in Q1 to 1.21 in Q4, reflecting greater predicted healthcare expenditure among surgeons already performing lower annual TSA volume. Beyond medical complexity, higher dual-eligibility quartiles also had greater psychosocial complexity, including higher proportions of anxiety (24 vs. 29%, P < .001) and depression (22 vs. 27%, P < .001). These factors are often poorly captured by traditional comorbidity indices.6,12 Together, these findings underscore a concerning pattern in which increased patient complexity coincides with lower annual TSA volume. Critically, there has been a sustained trend of decreasing reimbursement rates for shoulder surgeons for several decades—important context for the reimbursement findings of the present study.14,17,19 In a recent analysis of Medicare data from 2000 to 2025, Joshi et al14 reported substantial inflation-adjusted reimbursement decline for TSA, from $2,467.96 in 2000 to $1,433.64 in 2025. In the present study, we found a significant reduction in mean standardized reimbursement as dual-eligibility proportion increased, declining from $936.20 in Q1 to $799.18 in Q4 (P < .001), even after controlling for beneficiary HCC score risk, minority beneficiary proportion, and rurality (β = −7.751, P < .001), confirming that this phenomenon is distributed across geographic settings, not just rural or underserved areas. We propose that reduced surgeon reimbursement creates a financial disincentive for higher-volume surgeons to accept or prioritize dual-eligible patients, which over time may contribute to concentrating this population among lower-volume surgeons, compounding the access inequality documented above. Notably, while hospital-level differential reimbursement based on patient risk has been described in the arthroplasty literature, this has not yet been found at the surgeon level.5,18 Demopoulos et al5, using the 2022 version of the present database, reported significantly higher hospital reimbursement for TSA in high-risk patients (HCC ≥1.5 vs. <1.5). However, no corresponding difference was identified at the surgeon level, suggesting that the financial burden of caring for high-risk patients falls disproportionately on the surgeon.5 The present study extends this observation, demonstrating that at the surgeon level, those with the highest dual-eligibility proportion, and by extension the greatest patient complexity, are receiving the lowest standardized reimbursement. These findings should be interpreted in the context of several potential limitations, including all those associated with a retrospective database study design and the inability to establish causality. The minimum billing threshold of 11 cases in the CMS database excludes the lowest volume surgeons, potentially underestimating the true magnitude of volume disparity seen. Additionally, dual-eligibility proportion is a panel-level proxy, as such, individual patient-level insurance status and decision-making cannot be assessed. Specifically, the CMS By Provider and Service file, which allows filtering by CPT code, contains no dual-eligibility variable, while the By Provider file, which contains aggregated dual-eligibility counts per surgeon, is not procedure-specific. These files cannot be bridged at the patient level, precluding the ability to determine what percentage of each surgeon's TSA cohort was dual-eligible. Patient-level confirmation of this relationship would require access to the Medicare Standard Analytical Files, which are not publicly available. This limitation prevents patient-level inference but does not change the CPT-specific reimbursement measure. Separately, we cannot account for surgeon selection behavior, referral patterns, or patient preferences. Furthermore, the CMS dataset captures only fee-for-service beneficiaries, excluding Medicare Advantage beneficiaries, which represents a growing segment of the Medicare population, thus limiting generalizability.10 Missing data in panel-level CMS variables reduced the number of surgeons included in quartile-based analyses and may introduce selection bias. Many surgeons are employed and compensated through relative value unit–based models, so differences in Medicare reimbursement may not directly translate to individual surgeon compensation and may be more relevant at the practice or health-system level. These findings are specific to the U.S. Medicare fee-for-service population and may not generalize to other payers or health systems. In summary, surgeons caring for higher proportions of dual-eligible beneficiaries manage more medically complex patient panels, perform fewer TSAs, and receive lower standardized reimbursement per TSA. The non-significant finding in rurality across dual-eligibility quartiles suggests that the observed association is not explained solely by rural practice location. If reimbursement compression continues without adjustment for patient complexity, these disparities are likely to widen, making it more difficult for the most vulnerable patients to access higher-volume surgical care. Without structural reform, the financial disincentives currently at play risk amplifying the access to care disparities seen in the present study. Conclusion Surgeons with higher proportions of dual-eligible beneficiaries in their Medicare panels receive lower standardized reimbursement while managing more medically and psychosocially complex patient panels. These findings suggest that the current reimbursement structure may create financial disincentives for surgeons treating this socioeconomically vulnerable population, with implications for equitable access to TSA care. Disclaimers: Funding: No funding was disclosed by the authors. Conflicts of interest: Michael C. Fu serves on the Editorial or Governing Board for Arthroscopy and the HSS Journal and is a consultant for Stryker. Samuel A. Taylor is a designer for DonJoy Orthopedics and receives honoraria from DonJoy Orthopedics. Joshua S. Dines serves as a Board or Committee Member of ASES, is a consultant for Arthrex, receives royalties from Arthrex and Conmed Linvatec, receives research support from Arthrex and HSS, receives publishing royalties from Thieme Inc. and Lippincott Williams & Wilkins, and serves on the Board of Directors of Viewfi. Gabriella E. Ode serves as an Exactech consultant and on the Exactech Speakers' Bureau, and serves as a Board or Committee Member of ASES, AAOS, and AANA. David M. Dines is a Board or Committee Member for ASES and AAOS, receives publishing royalties from Thieme Inc., is a paid consultant for Wright Medical Technology, serves on the Editorial Board for Springer, serves as a Zimmer Biomet Inc. consultant, and receives royalties for the design and invention of bi-modular, total, and comprehensive shoulder replacement systems. Lawrence V. Gulotta serves as an Exactech consultant and on the Exactech Speakers' Bureau, has an ownership interest in Responsive Arthroscopy, has an ownership interest in Imagen Inc., serves on the Smith & Nephew Speakers' Bureau, serves as a Zimmer Biomet, Inc. consultant and on its Speakers' Bureau, and serves on the Editorial or Governing Board for the HSS Journal. Christopher M. Brusalis has received honoraria from Enovis, Inc. Any additional authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. Footnotes Institutional review board approval was not required for this review. References